Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients ...

A recent U.S. warning on use of 'march-in' rights against Harvard University seems like distant threat for pharma. Here's why ...

Keeping blood pressure below 120/80 lowers risk of dementia, as well as heart and kidney disease, new guidelines say.

Kornbluth learned lessons from the Duke cancer fraud case that “have powerfully shaped my approach to leadership ever since.” ...

A handful of drug companies have formed a group to present lawmakers with research on the negative impacts of Medicare drug ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Inner speech — the internal monologue in your brain as you think about what to say — can be decoded by computers and might ...

For more on Prasad’s return, go here; for a “Matt’s Take” on Prasad, go here; for the latest on investors’ attitudes toward ...

Can Boston stay on top in biotech? Find out on Sept 17, 6-9 p.m. EDT to explore talent shifts, funding, and Boston’s future.

If you’ll be at Epic’s User Group Meeting next week, 1) I hope you get some good frozen custard or cheese curds while you’re ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

“None of the other science agencies in HHS — NIH, FDA, nor CDC — focus on actually improving the quality of care that ...